VolitionRx Limited (VNRX)
NYSEAMERICAN: VNRX · Real-Time Price · USD
0.6900
+0.0336 (5.12%)
Aug 29, 2025, 4:00 PM - Market closed
VolitionRx Stock Forecast
Stock Price Forecast
The 3 analysts that cover VolitionRx stock have a consensus rating of "Strong Buy" and an average price target of $3.50, which forecasts a 407.25% increase in the stock price over the next year. The lowest target is $2.50 and the highest is $5.00.
Price Target: $3.50 (+407.25%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for VolitionRx stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 3 | 4 | 4 | 3 |
| Buy | 1 | 1 | 1 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 5 | 5 | 5 | 5 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $5 | Strong Buy | Maintains | $5 | +624.64% | Aug 15, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $5 | Strong Buy | Maintains | $5 | +624.64% | Jul 17, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $5 | Strong Buy | Maintains | $5 | +624.64% | Jul 9, 2025 |
| Jones Trading | Jones Trading | Strong Buy Initiates $3 | Strong Buy | Initiates | $3 | +334.78% | Jun 10, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $5 | Strong Buy | Maintains | $5 | +624.64% | Apr 30, 2025 |
Financial Forecast
Revenue This Year
4.62M
from 1.23M
Increased by 274.46%
Revenue Next Year
14.44M
from 4.62M
Increased by 212.60%
EPS This Year
-0.19
from -0.31
EPS Next Year
-0.08
from -0.19
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 17.8M | 30.7M | |||
| Avg | 4.6M | 14.4M | |||
| Low | 1.3M | 2.5M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1,344.8% | 565.2% | |||
| Avg | 274.5% | 212.6% | |||
| Low | 5.4% | -45.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.08 | 0.09 | |||
| Avg | -0.19 | -0.08 | |||
| Low | -0.21 | -0.18 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.